Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Pelvic floor muscle training for women with myotonic dystrophy

Official title: Pelvic Floor Muscle Training for Urinary Incontinence in Women with Myotonic Dystrophy Type 1: a Feasibility and Acceptability Study

Run by Université de Sherbrooke · NCT06316778 · Data updated 2026-11-12

This study is testing if pelvic floor muscle training can help women with myotonic dystrophy who have trouble with urinary incontinence feel better.

More Urinary Incontinence trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment12 (estimated)
SponsorUniversité de Sherbrooke
Academic / other
Locations1 site (Jonquière, Quebec)
StatusRecruiting
StartedMarch 11, 2024
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedFebruary 24, 2025
Trial IDNCT06316778 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women with a confirmed diagnosis of myotonic dystrophy type 1 who experience urinary incontinence.

Probably not a fit

Patients who are pregnant, have recently given birth, or have significant medical conditions affecting urinary incontinence may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the feasibility and effects of pelvic floor muscle (PFM) training in women diagnosed with myotonic dystrophy type 1 (DM1) who experience urinary incontinence. The intervention aims to strengthen the pelvic floor muscles, which may alleviate urinary incontinence symptoms that are common in this population. A quasi-experimental design will be employed, involving 12 women with confirmed DM1 and varying types of urinary incontinence. The study seeks to determine both the acceptability of the training and its potential benefits for improving urinary function.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce or eliminate urinary incontinence in women with myotonic dystrophy type 1.

How similar studies have gone: While pelvic floor muscle training has shown effectiveness in the general population, this specific application in myotonic dystrophy type 1 is novel and has not been previously tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* confirmed medical diagnosis of myotonic dystrophy type 1 (DM1) with adult phenotype
* symptoms of stress, urge or mixed urinary incontinence
* able to give a free and informed consent

Exclusion Criteria:

* being pregnant, have given birth by vaginal delivery in the last year or plan to become pregnant in the next six months
* present post-void residual urine ≥ 150 ml
* have medical conditions that may have an impact on the symptoms of urinary incontinence and the response to treatments
* present fecal incontinence (≥ 1/week) or significant prolapse (beyond the hymen)
* have already received physiotherapy treatments in pelvic floor rehabilitation or surgery on the perineum
* have a defibrillator, pacemaker or bladder stimulator

Where it's running

  • Clinique des maladies neuromusculaires
    Jonquière, Quebec, Canada
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.